Macroaxis considers Exalenz Bioscience to be unknown risk. Exalenz Bioscience secures Sharpe Ratio (or Efficiency) of -0.1246 which denotes Exalenz Bioscience had -0.1246% of return per unit of standard deviation over the last 2 months. Macroaxis philosophy in predicting risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Exalenz Bioscience Ltd exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Exalenz Bioscience Mean Deviation of 2.69 to check risk estimate we provide.
|Horizon||30 Days Login to change|
Exalenz Bioscience Market Sensitivity
|As returns on market increase, returns on owning Exalenz Bioscience are expected to decrease at a much smaller rate. During bear market, Exalenz Bioscience is likely to outperform the market.2 Months Beta |Analyze Exalenz Bioscience Demand TrendCheck current 30 days Exalenz Bioscience correlation with market (DOW)|
β = -0.3266
Exalenz Bioscience Central Daily Price Deviation
Exalenz Bioscience Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Exalenz Bioscience Projected Return Density Against MarketAssuming 30 trading days horizon, Exalenz Bioscience Ltd has beta of -0.3266 suggesting as returns on benchmark increase, returns on holding Exalenz Bioscience are expected to decrease at a much smaller rate. During bear market, however, Exalenz Bioscience Ltd is likely to outperform the market. Additionally, Exalenz Bioscience Ltd has a negative alpha implying that the risk taken by holding this equity is not justified. The company is significantly underperforming DOW
Predicted Return Density
Assuming 30 trading days horizon, the coefficient of variation of Exalenz Bioscience is -802.51. The daily returns are destributed with a variance of 51.98 and standard deviation of 7.21. The mean deviation of Exalenz Bioscience Ltd is currently at 4.24. For similar time horizon, the selected benchmark (DOW) has volatility of 1.29
|Alpha over DOW||=||0.87|
|Beta against DOW||=||0.33|
Exalenz Bioscience Return VolatilityExalenz Bioscience Ltd accepts 7.2096% volatility on return distribution over the 30 days horizon. DOW inherits 1.2919% risk (volatility on return distribution) over the 30 days horizon.
Exalenz Bioscience Ltd has a volatility of 7.21 and is 5.59 times more volatile than DOW. 65% of all equities and portfolios are less risky than Exalenz Bioscience. Compared to the overall equity markets, volatility of historical daily returns of Exalenz Bioscience Ltd is higher than 65 (%) of all global equities and portfolios over the last 30 days. Use Exalenz Bioscience Ltd to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Exalenz Bioscience to be traded at S760.61 in 30 days. As returns on market increase, returns on owning Exalenz Bioscience are expected to decrease at a much smaller rate. During bear market, Exalenz Bioscience is likely to outperform the market.
Exalenz Bioscience correlation with market